McDermott + Bull has placed Mike Feher as Vice President of Finance and Chief Financial Officer for CathWorks. CathWorks was looking for a top financial executive who could lead the company through the next level of scale for U.S. commercialization, an exciting time in their history. CathWorks has pioneered new technology with the potential to completely disrupt the industry by changing the treatment algorithm for percutaneous cardiac intervention (PCI).
With over 13 years of finance and strategy experience in companies such as Edwards Lifesciences, THV, Volcom, and Deloitte, Mike’s skillset and work style is a great addition to the team. His experience will set an expectation of excellent collaboration and solid execution as they roll out their new technology in California and eventually across the U.S.
CathWorks is a medical technology company focused on optimizing PCI therapy decisions and elevating coronary angiography to an objective FFR-based tool for physicians. FFR-guided PCI decision-making is proven to provide significant clinical benefits for patients with coronary artery disease and economic benefits for patients and payers. CathWorks is specifically focusing on bringing the CathWorks FFRangio™ System to market to provide quick, precise, and objective intraprocedural FFR guidance that is practical for every case.